Seamless transition from R&D to clinical and commercial manufacturing.
Automated cell expansion and harvest. Small- to mid-scale batch sizes.
Assuring product quality and minimizing costs.
Easier cGMP translation and shorter time to market.
The ideal solution for autologous products and redistributed scale-out manufacturing.
The components you already know.
Engineered in an easy-to-load, single-use, closed-system for safe and cGMP-compliant cell processing.
Built-in microscope, confluence estimation and in-process controls.
High medicinal product standardization. Remote access for monitoring, always at your fingertips.
VivaBioCell at iCAST 2018
We will be attending the 4th International Congress on Adipose Stem Cell Treatments at iCAST 2018 organized by the Swiss Stem Cell Foundation in Zurich on the 29th May 2018! Prof. Francesco Curcio, Founder of VivaBioCell, will give a talk entitled: "Regenerative medicine in osteoarthritis: overcoming cell-product manufacturing hurdles with the automated NANT 001 System". Attendees will also have a chance to learn more on the NANT 001 System by stopping by at our booth. Be there! Read more ›
VivaBioCell at World Advanced Therapy and Regenerative Medicine Congress 2018
Come and meet us by Stand 42 at The World Advanced Therapy and Regenerative Medicine Congress 2018 (London, 16-18 May), to learn more on how VivaBioCell can support you in developing small- to mid-scale batch size products with innovative automated solutions for cell-based and and cell-derived product manufacturing! Read more ›
POR FESR 2014-2020 FVG: OPPORTUNITA' PER UNA CRESCITA SOSTENIBILE.
VivaBioCell is a beneficiary of SISICOR (Sistema Implantare per la Stabilità immediata di impianto in Chirurgia Orale di Ricostruzione), a project approved under the POR FESR 2014-2020 Friuli Venezia Giulia. Read more ›